Lewis T. "Rusty" Williams | MD, PhD
Co-Founder, Executive Chairman
Founder and Chairman of Five Prime Therapeutics.
Chief Scientific Officer & board member , Chiron Corporation (now Novartis Vaccines and Diagnostics, Inc.),
Professor of medicine, UCSF and director of Cardiovascular Research Institution and Daiichi Research Center.
Member of National Academy of Sciences and fellow of the American Academy of Arts and Sciences.
B.S. Rice University; M.D./Ph.D. Duke University.
Reddy Moola | PHD
CEO, Co-Founder, and Board Director
PhD from Indian Institute of Chemical Technology with Dr. J.S Yadav.
Faculty at UT Southwestern Medical Center, Dallas and The Scripps Research Institute.
Published and patented > 50 novel small molecule and peptoid-based technologies.
Inventor of the Anven’s core technology platform.
Bill Shelander | MSE, MBA
COO, Co-Founder, and Board Director
MBA from Stanford University; MS in Chemical Engineering
30+ years of VC management and start ups in advanced technologies
Commercialization expert at Lawrence Berkeley National Lab
Faculty of Stanford University and Haas School of Business, UC Berkeley
Roger Wong | Phd, MBA
SVP, Research and Development
PhD in biochemistry, UC Berkeley; MBA at Hough business school at UF.
Faculty member directing and publishing publicly funded research projects.
Expert in metabolic disease, insulin signaling, cancer, immunology, neurodegenerative disease
Seasoned scientist in biotech , diagnostic and pharmaceutical sectors
Ronald Zuckermann | PhD
Co-Founder, Board Director, and Chairman SAB
PhD from UC Berkeley in Bioorganic Chemistry with Dr. Peter Schultz; published >140 papers, 38 patents.
Director of Biological Nanostructures, Lawrence Berkeley National Lab http://www.ronznet.com
Invented class of heteropolymers called "Peptoids“ in early 1990’s.
A founding chemist at Protos Corp. (drug discovery venture)